Neuropathic Pain News and Research

RSS
Neuropathic pain is a type of pain that is caused by damage to the nervous system following an injury or illness and affects approximately 1% of the population.

Further Reading

Cannabis and Cannabinoid Research journal supports President Obama's statement on medical use of marijuana

Cannabis and Cannabinoid Research journal supports President Obama's statement on medical use of marijuana

Immune Pharmaceuticals begins bertilimumab Phase II clinical trials in Bullous Pemphigoid, Ulcerative Colitis

Immune Pharmaceuticals begins bertilimumab Phase II clinical trials in Bullous Pemphigoid, Ulcerative Colitis

FASEB honors Max Planck Florida scientist with Glaxo Smith Kline Neuroscience Discovery Award

FASEB honors Max Planck Florida scientist with Glaxo Smith Kline Neuroscience Discovery Award

Benitec, ReNeuron collaborate to launch new exploratory cellular therapy program

Benitec, ReNeuron collaborate to launch new exploratory cellular therapy program

INS announces winners of inaugural best abstract competition at 12th World Congress

INS announces winners of inaugural best abstract competition at 12th World Congress

International Neuromodulation Society recognizes third Giant of Neuromodulation

International Neuromodulation Society recognizes third Giant of Neuromodulation

Weekly sessions of non-invasive brain stimulation improve outcomes in patients with post-stroke pain

Weekly sessions of non-invasive brain stimulation improve outcomes in patients with post-stroke pain

Duke Medicine scientists produce 3-D map of human brain stem using MRI technology

Duke Medicine scientists produce 3-D map of human brain stem using MRI technology

Canadian researchers shed light on molecular dynamics of chronic pain

Canadian researchers shed light on molecular dynamics of chronic pain

Scientists find new way to convert blood cells into sensory neurons

Scientists find new way to convert blood cells into sensory neurons

Immune Pharmaceuticals announces Q1 2015 financial results; files Quarterly Report on Form 10-Q

Immune Pharmaceuticals announces Q1 2015 financial results; files Quarterly Report on Form 10-Q

Pain management webinar addresses fibromyalgia, "the invisible disease"

Pain management webinar addresses fibromyalgia, "the invisible disease"

Fifth patient dosed in Benitec's TT-034 Phase I/IIa clinical trial for prevention of HCV infection

Fifth patient dosed in Benitec's TT-034 Phase I/IIa clinical trial for prevention of HCV infection

OHTAC recommends MRgHIFU as possible cost-effective strategy for uterine fibroid treatment

OHTAC recommends MRgHIFU as possible cost-effective strategy for uterine fibroid treatment

New Cannabis and Cannabinoid Research journal to be launched in fall 2015

New Cannabis and Cannabinoid Research journal to be launched in fall 2015

New brain mapping model could improve success rate of transcranial magnetic stimulation

New brain mapping model could improve success rate of transcranial magnetic stimulation

Combining nortriptyline and morphine successfully relieves chronic neuropathic pain

Combining nortriptyline and morphine successfully relieves chronic neuropathic pain

Depomed acquires U.S. rights to NUCYNTA franchise from Janssen Pharmaceuticals

Depomed acquires U.S. rights to NUCYNTA franchise from Janssen Pharmaceuticals

Fourth patient dosed in Benitec Biopharma's Phase I/IIa hepatitis C trial

Fourth patient dosed in Benitec Biopharma's Phase I/IIa hepatitis C trial

United Therapeutics announces FDA approval of dinutuximab for treatment of high-risk neuroblastoma

United Therapeutics announces FDA approval of dinutuximab for treatment of high-risk neuroblastoma